Humoral immunity and the development of obliterative bronchiolitis after lung transplantation

Is there a link?

Amir M. Emtiazjoo, David S. Wilkes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Lung transplantationis considered the definitive treatment for many end-stage lung diseases. However, the lung is rejected more commonly than other solid organ allografts. Obliterative bronchiolitis (OB) is the leading cause of chronic allograft dysfunction, and the key reason why the 5-year survival of lung transplant recipients is only 50%. The pathophysiology of OB is incompletely understood. Although a clear role for the immune response to donor antigens has been observed (also known as anti-human leukocyte antigens), evidence is emerginga bout the role of autoimmunity to self-antigens. This review highlights the current understanding of humoral immunity in the development of OB after lung transplantation.

Original languageEnglish
Pages (from-to)145-149
Number of pages5
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume48
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Bronchiolitis
Lung Transplantation
Humoral Immunity
Allografts
Lung
Pulmonary diseases
Transplants
Autoantigens
HLA Antigens
Autoimmunity
Antigens
Lung Diseases
Therapeutics

Keywords

  • Antibodies
  • Lung transplant
  • Obliterative bronchiolitis
  • Rejection

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Humoral immunity and the development of obliterative bronchiolitis after lung transplantation : Is there a link? / Emtiazjoo, Amir M.; Wilkes, David S.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 48, No. 2, 02.2013, p. 145-149.

Research output: Contribution to journalArticle

@article{4bf077e0fbeb47a5af4a714a6b67841d,
title = "Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: Is there a link?",
abstract = "Lung transplantationis considered the definitive treatment for many end-stage lung diseases. However, the lung is rejected more commonly than other solid organ allografts. Obliterative bronchiolitis (OB) is the leading cause of chronic allograft dysfunction, and the key reason why the 5-year survival of lung transplant recipients is only 50{\%}. The pathophysiology of OB is incompletely understood. Although a clear role for the immune response to donor antigens has been observed (also known as anti-human leukocyte antigens), evidence is emerginga bout the role of autoimmunity to self-antigens. This review highlights the current understanding of humoral immunity in the development of OB after lung transplantation.",
keywords = "Antibodies, Lung transplant, Obliterative bronchiolitis, Rejection",
author = "Emtiazjoo, {Amir M.} and Wilkes, {David S.}",
year = "2013",
month = "2",
doi = "10.1165/rcmb.2012-0349RT",
language = "English",
volume = "48",
pages = "145--149",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Humoral immunity and the development of obliterative bronchiolitis after lung transplantation

T2 - Is there a link?

AU - Emtiazjoo, Amir M.

AU - Wilkes, David S.

PY - 2013/2

Y1 - 2013/2

N2 - Lung transplantationis considered the definitive treatment for many end-stage lung diseases. However, the lung is rejected more commonly than other solid organ allografts. Obliterative bronchiolitis (OB) is the leading cause of chronic allograft dysfunction, and the key reason why the 5-year survival of lung transplant recipients is only 50%. The pathophysiology of OB is incompletely understood. Although a clear role for the immune response to donor antigens has been observed (also known as anti-human leukocyte antigens), evidence is emerginga bout the role of autoimmunity to self-antigens. This review highlights the current understanding of humoral immunity in the development of OB after lung transplantation.

AB - Lung transplantationis considered the definitive treatment for many end-stage lung diseases. However, the lung is rejected more commonly than other solid organ allografts. Obliterative bronchiolitis (OB) is the leading cause of chronic allograft dysfunction, and the key reason why the 5-year survival of lung transplant recipients is only 50%. The pathophysiology of OB is incompletely understood. Although a clear role for the immune response to donor antigens has been observed (also known as anti-human leukocyte antigens), evidence is emerginga bout the role of autoimmunity to self-antigens. This review highlights the current understanding of humoral immunity in the development of OB after lung transplantation.

KW - Antibodies

KW - Lung transplant

KW - Obliterative bronchiolitis

KW - Rejection

UR - http://www.scopus.com/inward/record.url?scp=84873348880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873348880&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2012-0349RT

DO - 10.1165/rcmb.2012-0349RT

M3 - Article

VL - 48

SP - 145

EP - 149

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 2

ER -